The Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with ...

The radioligand agent is now approved for use before chemotherapy in patients who have been treated with an androgen receptor pathway inhibitor.

Buckingham Palace announced that the King had been diagnosed with cancer while he was undergoing a separate procedure for an ...

King Charles left royal fans concerned following the news he had cancelled several engagements due to a "brief" hospital ...

FDA expands Pluvicto indication to adults with PSMA+ metastatic castration-resistant prostate cancer previously treated with ...

In the study, Pluvicto (lutetium Lu 177 vipivotide tetraxetan) reduced the risk of radiographic progression or death by 59% ...

King Charles III took a trip to the hospital on Thursday because of side effects from his ongoing cancer treatment.

Charles’ appearance comes just one day after he was hospitalized — and forced to cancel his engagements — over “temporary” side effects from his treatment.

The side effects of King Charles's cancer treatment "required a short period of observation in hospital", Buckingham Palace ...

King Charles has returned to Clarence House after a brief hospital stay. His hospitalisation was sparked by side effects from ...

Here's everything we know about King Charles's health, from his cancer diagnosis to his treatment and recovery so far.

The king has been undergoing treatment since he was diagnosed with an unspecified form of cancer in February last year ...